IS THERE A MORTALITY BENEFIT WITH RENIN-ANGIOTENSIN SYSTEM (RAS) INHIBITION IN AFRICAN AMERICANS (AA) WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)?
Conference
Valadri, Ravinder R, Veledar, Emir, Gadesam, Radhika et al. (2012). IS THERE A MORTALITY BENEFIT WITH RENIN-ANGIOTENSIN SYSTEM (RAS) INHIBITION IN AFRICAN AMERICANS (AA) WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)?
. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 59(13), E960-E960. 10.1016/S0735-1097(12)60961-9
Valadri, Ravinder R, Veledar, Emir, Gadesam, Radhika et al. (2012). IS THERE A MORTALITY BENEFIT WITH RENIN-ANGIOTENSIN SYSTEM (RAS) INHIBITION IN AFRICAN AMERICANS (AA) WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)?
. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 59(13), E960-E960. 10.1016/S0735-1097(12)60961-9